Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors.
Bioorg Med Chem Lett
; 24(15): 3398-402, 2014 Aug 01.
Article
em En
| MEDLINE
| ID: mdl-24939756
Extensive phase II metabolism of an advanced PKCε inhibitor resulted in sub-optimal pharmacokinetics in rat marked by elevated clearance. Synthesis of the O-glucuronide metabolite as a standard was followed by three distinct strategies to specifically temper phase II metabolic degradation of the parent molecule. In this study, it was determined that the introduction of proximal polarity to the primary alcohol generally curbed O-glucuronidation and improved PK and physical chemical properties while maintaining potency against the target. Utilization of a Jacobsen hydrolytic kinetic resolution to obtain optically enriched final compounds is also discussed.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Glucuronídeos
/
Inibidores de Proteínas Quinases
/
Proteína Quinase C-épsilon
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article